Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 1
2010 2
2012 2
2013 1
2015 5
2016 3
2017 4
2019 6
2020 4
2021 4
2022 2
2023 4
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients' view?
Lacroix C, Guilhaumou R, Micallef J, Bruneteau G, Desnuelle C, Blin O. Lacroix C, et al. Rev Neurol (Paris). 2023 Nov;179(9):967-974. doi: 10.1016/j.neurol.2023.03.018. Epub 2023 Jul 16. Rev Neurol (Paris). 2023. PMID: 37460332
Cannabis may have therapeutic benefits to relieve symptoms of amyotrophic lateral sclerosis (ALS) thanks to its pleiotropic pharmacological activity. This study is the first to present a large questionnaire-based survey about the "real-life" situation regardi …
Cannabis may have therapeutic benefits to relieve symptoms of amyotrophic lateral sclerosis (ALS) thanks to its pleiotr …
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L, Bisogno T, Di Marzo V. Cristino L, et al. Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12. Nat Rev Neurol. 2020. PMID: 31831863 Review.
Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid delta(9)-tetrahydrocannabinol (THC) initiated efforts to develop cannabinoid-based therapeutics. ...In this Review, we provide an overview …
Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid …
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R. Deepmala, et al. Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Neurosci Biobehav Rev. 2015. PMID: 25957927 Free article.
In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly autism, Alzheimer's disease, cocaine and cannabis addiction, bipolar disorder, depression, trichotillomania, nail biting, skin picking, o …
In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly auti …
Cannabis and cannabinoids.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Nov 18;61(1585):179-182. Med Lett Drugs Ther. 2019. PMID: 31770357 Review. No abstract available.
Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.
Urbi B, Broadley S, Bedlack R, Russo E, Sabet A. Urbi B, et al. BMJ Open. 2019 Nov 11;9(11):e029449. doi: 10.1136/bmjopen-2019-029449. BMJ Open. 2019. PMID: 31719072 Free PMC article.
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life expectancy of 3-5 years post diagnosis. ...METHODS AND ANALYSIS: The Efficacy of cannabis-based Medicine Extract in slowing the disea …
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life …
Survey of cannabis use in patients with amyotrophic lateral sclerosis.
Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Amtmann D, et al. Am J Hosp Palliat Care. 2004 Mar-Apr;21(2):95-104. doi: 10.1177/104990910402100206. Am J Hosp Palliat Care. 2004. PMID: 15055508
Cannabis (marijuana) has been proposed as treatment for a widening spectrum of medical conditions and has many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). This study is the first, anonymous survey of persons wit …
Cannabis (marijuana) has been proposed as treatment for a widening spectrum of medical conditions and has many properties that may be …
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Pryce G, Baker D. Pryce G, et al. Handb Exp Pharmacol. 2015;231:213-31. doi: 10.1007/978-3-319-20825-1_7. Handb Exp Pharmacol. 2015. PMID: 26408162 Review.
There are numerous reports that people with multiple sclerosis (MS) have for many years been self-medicating with illegal street cannabis or more recently medicinal cannabis to alleviate the symptoms associated with MS and also amyotrophic lateral scle …
There are numerous reports that people with multiple sclerosis (MS) have for many years been self-medicating with illegal street cannabis …
Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.
Carter GT, Abood ME, Aggarwal SK, Weiss MD. Carter GT, et al. Am J Hosp Palliat Care. 2010 Aug;27(5):347-56. doi: 10.1177/1049909110369531. Epub 2010 May 3. Am J Hosp Palliat Care. 2010. PMID: 20439484
Significant advances have increased our understanding of the molecular mechanisms of amyotrophic lateral sclerosis (ALS), yet this has not translated into any greatly effective therapies. ...With respect to the treatment of ALS, from both a disease modifying and sym …
Significant advances have increased our understanding of the molecular mechanisms of amyotrophic lateral sclerosis (ALS), yet …
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway.
Talebi M, Sadoughi MM, Ayatollahi SA, Ainy E, Kiani R, Zali A, Miri M. Talebi M, et al. Biomed Pharmacother. 2023 Oct 28;168:115805. doi: 10.1016/j.biopha.2023.115805. Online ahead of print. Biomed Pharmacother. 2023. PMID: 39491419 Free article. Review.
Specifically, Nrf2 is connected to the initiation and progression of diverse health issues, including nephrotoxicity, bladder-related diseases, oral mucositis, cancers, obesity, myocardial injury and angiogenesis, skin-related inflammations, psychotic disorders, neuropathic pain, …
Specifically, Nrf2 is connected to the initiation and progression of diverse health issues, including nephrotoxicity, bladder-related diseas …
Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications.
Denton TT, Carter GT, Goddard M, Weiss J, Weeks DL, Weydt P, Russo EB, Weiss MD. Denton TT, et al. Muscle Nerve. 2025 Jul;72(1):7-14. doi: 10.1002/mus.28359. Epub 2025 Feb 12. Muscle Nerve. 2025. PMID: 39936266 Review.
A unifying mechanistic cause for amyotrophic lateral sclerosis (ALS) remains uncertain. Multiple pathophysiological processes appear to occur simultaneously. Cannabinoids, including delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other …
A unifying mechanistic cause for amyotrophic lateral sclerosis (ALS) remains uncertain. Multiple pathophysiological processes …
45 results